Reshma Kewalramani

Insider Reports History

Entity
Individual
Location
C/O Vertex Pharmaceuticals, Inc., 50 Northern Avenue, Boston, Massachusetts
Signature
/s/ Karen Tepichin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reshma Kewalramani:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA CEO & President, Director Common Stock 121,374 $55.5 M $457.00 May 24, 2024 Direct
VERTEX PHARMACEUTICALS INC / MA CEO & President, Director Stock Option (Right to Buy) 0 $200 K $127.54 May 24, 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 186,002 $102 K $0.55 Jun 12, 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Restricted Stock Units 0 $0 $0.55 Jun 12, 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Stock Option 139,860 Jun 16, 2023 Direct

Insider Reports Filed by Reshma Kewalramani

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNA Ginkgo Bioworks Holdings, Inc. Jun 12, 2024 2 0 4 Jun 14, 2024 Director
VRTX VERTEX PHARMACEUTICALS INC / MA May 24, 2024 3 -421,721 4 May 29, 2024 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA May 20, 2024 1 -6,795,294 4 May 22, 2024 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 23, 2024 1 -4,052,781 4 Feb 27, 2024 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 16, 2024 2 -6,920,361 4 Feb 21, 2024 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 9, 2024 1 -3,489,719 4 Feb 13, 2024 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 6, 2024 3 0 4 Feb 8, 2024 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Dec 15, 2023 5 -3,858,352 4 Dec 19, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Dec 13, 2023 1 -2,023,906 4 Dec 15, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 13, 2023 1 -1,921,569 4 Nov 15, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Jul 17, 2023 1 -2,778,940 4 Jul 18, 2023 CEO & President, Director
DNA Ginkgo Bioworks Holdings, Inc. Jun 16, 2023 2 0 4 Jun 21, 2023 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 27, 2023 3 -1,124,726 4 May 1, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2023 1 -2,713,680 4 Feb 28, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2023 1 -2,740,783 4 Feb 22, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2023 2 -2,779,058 4 Feb 14, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2023 3 0 4 Feb 3, 2023 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Jan 25, 2023 1 -3,150,500 4 Jan 27, 2023 CEO & President, Director
DNA Ginkgo Bioworks Holdings, Inc. Sep 30, 2022 2 0 4 Nov 10, 2022 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Aug 15, 2022 1 -3,565,846 4 Aug 17, 2022 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Jun 24, 2022 0 0 4/A Jul 21, 2022 CEO & President, Director
DNA Ginkgo Bioworks Holdings, Inc. Jun 10, 2022 2 0 4 Jun 13, 2022 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2022 1 -1,651,074 4 Feb 28, 2022 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2022 1 -1,995,866 4 Feb 22, 2022 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2022 1 -720,590 4 Feb 14, 2022 CEO & President, Director
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2022 3 0 4 Feb 3, 2022 CEO & President, Director
DNA Ginkgo Bioworks Holdings, Inc. Nov 19, 2021 1 0 4 Nov 23, 2021 Director
DNA Ginkgo Bioworks Holdings, Inc. Sep 16, 2021 2 0 4 Sep 20, 2021 Director
DNA Ginkgo Bioworks Holdings, Inc. Sep 16, 2021 0 0 3 Sep 20, 2021 Director
VRTX VERTEX PHARMACEUTICALS INC / MA Aug 19, 2021 2 1,956,492 4 Aug 23, 2021 CEO & President, Director